Researchers have uncovered a possible link between sterol biosynthesis inhibiting medications taken during pregnancy and an ...
Johnson & Johnson today announced findings from the first network meta-analysis (NMA) comparing CAPLYTA® (lumateperone) to FDA-approved atypical antipsychotics for add-on treatment of major depressive ...
Everyday Health on MSN
How to manage chorea in Huntington’s disease
Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results